Abbott Laboratories (ABT) Work In Process (2009 - 2026)

Abbott Laboratories has disclosed Work In Process across 18 years of filings, most recently posting $1.0 billion for Q2 2026.

• In Q2 2026, Work In Process rose 6.34% year-over-year to $1.0 billion; the TTM figure through Jun 2026 stood at $1.0 billion (up 6.34% YoY), while the FY2025 annual figure was $904.0 million, up 7.62% from the prior year.
• Work In Process came in at $1.0 billion for Q2 2026 at Abbott Laboratories, up from $994.0 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $1.0 billion in Q2 2026 to a low of $680.0 million in Q4 2022.
• Average Work In Process over 5 years is $853.8 million, with a median of $878.5 million recorded in 2024.
• Year-over-year, Work In Process declined 10.8% in 2022 and rose 22.31% in 2023.
• Over 5 years, Work In Process stood at $680.0 million in 2022, then grew by 18.68% to $807.0 million in 2023, then grew by 4.09% to $840.0 million in 2024, then grew by 7.62% to $904.0 million in 2025, then advanced by 13.16% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $1.0 billion in Q2 2026, $994.0 million in Q1 2026, and $904.0 million in Q4 2025.